Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Graf

Showing results (191-200 of 247) with videos related to

Pageof 25
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 2, 2025
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancerBrian M Slomovitz, Natalie Danziger, Julia C F Quintanilha, et al.
European Urology|December 17, 2016
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
JCO Precision Oncology|June 7, 2024
Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic MelanomaMiles C Andrews, Gerald Li, Ryon P Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast CarcinomaHope S Rugo, Kira Raskina, Alexa B Schrock, et al.
Advanced Healthcare Materials|October 26, 2024
A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine AdjuvantErin M Euliano, Brett H Pogostin, Anushka Agrawal, et al.
Journal of Chromatography. B, Biomedical Applications|May 19, 1995
Analytical procedure for the determination of the new antitumour drug N-benzoylstaurosporine and three potential metabolites in human plasma by reversed-phase high-performance liquid chromatographyR van Gijn, O van Tellingen, J J de Clippeleir, et al.
Journal for Immunotherapy of Cancer|January 17, 2023
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysisRichard S P Huang, David P Carbone, Gerald Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2022
Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes studyZ R Reichert, T M Morgan, G Li, et al.
Breast Cancer Research and Treatment|July 13, 2024
Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practiceManali A Bhave, Julia C F Quintanilha, Hanna Tukachinsky, et al.
Cancer Medicine|January 15, 2026
Emergence of BRCA Reversion Mutations in Prostate Cancer Prior to PARP Inhibitor Exposure: Clinical and Therapeutic ImplicationsDouglas I Lin, Elizabeth Lawrence, Natalie Danziger, et al.
Pageof 25

Showing results (191-200 of 247) with videos related to

Sort By:
Pageof 25
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 2, 2025
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancerBrian M Slomovitz, Natalie Danziger, Julia C F Quintanilha, et al.
European Urology|December 17, 2016
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
JCO Precision Oncology|June 7, 2024
Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic MelanomaMiles C Andrews, Gerald Li, Ryon P Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast CarcinomaHope S Rugo, Kira Raskina, Alexa B Schrock, et al.
Advanced Healthcare Materials|October 26, 2024
A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine AdjuvantErin M Euliano, Brett H Pogostin, Anushka Agrawal, et al.
Journal of Chromatography. B, Biomedical Applications|May 19, 1995
Analytical procedure for the determination of the new antitumour drug N-benzoylstaurosporine and three potential metabolites in human plasma by reversed-phase high-performance liquid chromatographyR van Gijn, O van Tellingen, J J de Clippeleir, et al.
Journal for Immunotherapy of Cancer|January 17, 2023
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysisRichard S P Huang, David P Carbone, Gerald Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2022
Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes studyZ R Reichert, T M Morgan, G Li, et al.
Breast Cancer Research and Treatment|July 13, 2024
Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practiceManali A Bhave, Julia C F Quintanilha, Hanna Tukachinsky, et al.
Cancer Medicine|January 15, 2026
Emergence of BRCA Reversion Mutations in Prostate Cancer Prior to PARP Inhibitor Exposure: Clinical and Therapeutic ImplicationsDouglas I Lin, Elizabeth Lawrence, Natalie Danziger, et al.
Pageof 25